Material matter: sonefpeglutide (LAPS GLP2 agonist, HM15912) licensed out
DART
Hanmi Pharm. Co., Ltd.
Filed Jun 1, 2026 KST · Filing
· receipt 20260601800011
kstock has not written this one up.
The title above is a translation of the Korean form name; the filing itself is on DART, in
Korean.
Read the original on DART ↗Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory
Service — the filing equivalent of EDGAR.
Korean form name: 투자판단관련주요경영사항 (소네페글루타이드 (Sonefpeglutide; LAPS GLP2 agonist; HM15912) 기술이전 계약 체결)